128 results
Page 4 of 7
6-K
EX-99.1
gnx9tvbi trai18
19 Mar 19
RepliCel Reignites its First-in-Japan Strategy
12:11pm
6-K
EX-99.2
un59xo3aa32
26 Nov 18
Current report (foreign)
4:20pm
6-K
EX-99.2
i0tdwlso
30 May 18
Condensed Consolidated Interim Financial Statements
12:00am
20-F/A
os5ynu4xe74hd ugbqf2
12 Jan 18
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
kvvzpoxny
25 Oct 17
Current report (foreign)
12:00am
6-K
EX-99.1
co2ho8h
20 Apr 16
RepliCel Life Sciences Finishes Enrolment for its Tendon Repair and Skin Rejuvenation Clinical Trials
12:00am
6-K
EX-99.1
fuxlmv9lskzp1mty
20 Oct 15
First Participants Enrolled in RepliCel's Phase 1 Clinical Trial of its RCS-01 Dermatology Injectable
12:00am
6-K
EX-99.1
bqgjlv
23 Jul 15
RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
12:00am
6-K
EX-99.1
89u7b24x0bx
23 Feb 15
RepliCel Submits Clinical Trial Application for its Dermatological Product
12:00am
CORRESP
oxafaeit2
6 Jan 15
Correspondence with SEC
12:00am
6-K
EX-99.1
m4ryrb8
22 Dec 14
Current report (foreign)
12:00am
6-K
EX-99.1
o1oiqj4y
1 Dec 14
RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis
12:00am
6-K
EX-99.2
ajr7gru
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
l4o78puhmg
29 Oct 14
RepliCel Submits Clinical Trial Application to Health Canada for its Chronic Achilles Tendinosis Trial
12:00am
6-K
EX-99.1
l99pc6gm kke4m25
3 Sep 14
RepliCel Life Sciences Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium
12:00am